Jyothy Labs approves Rs 147 crore tender buyback at Rs 215

Jyothy Labs Limited approved on November 4, 2026 a tender-offer buyback of up to 68,37,210 equity shares at Rs 215 each, with a maximum outlay of Rs 147 crore and Rs 150, excluding transaction costs; the quantity equals 1.86% of paid-up equity capital as at March 31, 2026.

What buyback has Jyothy Labs approved?

Jyothy Labs approved the repurchase of up to 68,37,210 fully paid equity shares with a face value of Rs 1 each at Rs 215 per share in cash. The maximum outlay is Rs 147 crore and Rs 150, excluding transaction costs including brokerage, stock-exchange charges, Securities and Exchange Board of India filing fees, advisory fees, legal fees, audit fees, publication costs and stamp duty.

Jyothy Labs selected the tender-offer route, under which eligible shareholders or beneficial owners on the record date may participate under the applicable buyback regulations and the Companies Act, 2013. The maximum quantity represents 1.86% of total paid-up equity share capital measured as at March 31, 2026, rather than an open-market repurchase programme.

Who can tender shares in the Jyothy Labs buyback?

Shareholders or beneficial owners holding Jyothy Labs shares on the November 11, 2026 record date can be eligible to participate, while the promoter and promoter group have stated that they will not participate. Jyothy Labs recorded that intention in a letter from the promoter and promoter group dated November 4, 2026.

Jyothy Labs has not provided a post-buyback shareholding pattern because the actual number of shares repurchased and the categories of shareholders from whom they are bought can be determined only after the record date. The disclosed pre-buyback shareholding pattern is dated October 30, 2026, while the public announcement and letter of offer will set out the tender process and timetable.

When is the Jyothy Labs buyback record date?

The Jyothy Labs buyback record date is Wednesday, November 11, 2026, and it will determine entitlement and identify shareholders or beneficial owners eligible to participate. The board fixed the date at its November 4, 2026 meeting, which began at 11:00 a.m. and concluded at 1:40 p.m.

Jyothy Labs has formed a buyback committee and delegated authority for actions, matters and decisions connected with the transaction. The public announcement and letter of offer have not yet been released, and Jyothy Labs said they will be issued in due course under the Securities and Exchange Board of India Buy-Back of Securities Regulations, 2018.

Can Jyothy Labs change the Rs 215 buyback price?

Jyothy Labs can increase the Rs 215 buyback price and reduce the proposed number of shares until one working day before November 11, 2026, provided the buyback size does not change. This flexibility is available to the board or buyback committee under Regulation 5(via) of the buyback regulations.

The stated maximum size of Rs 147 crore and Rs 150 represents 9.70% of Jyothy Labs' aggregate fully paid-up equity share capital and free reserves under audited financial statements for the year ended March 31, 2026. Jyothy Labs said this is within the 10% statutory limit for the board-approval route, so a price increase under the disclosed mechanism would require a lower maximum share quantity without increasing the outlay.

What do Jyothy Labs' latest financial results show?

Jyothy Labs reported revenue from operations of Rs 760.04 crore for the quarter ended September 30, 2026, compared with Rs 736.06 crore for the quarter ended September 30, 2025. Net profit fell to Rs 10.60 crore from Rs 87.76 crore, while profit before tax declined to Rs 16.38 crore from Rs 118.69 crore.

For the half year ended September 30, 2026, Jyothy Labs' revenue from operations rose to Rs 1,533.44 crore from Rs 1,487.27 crore a year earlier, but net profit fell to Rs 58.24 crore from Rs 184.55 crore. Cost of materials consumed increased to Rs 985.08 crore from Rs 737.54 crore over the same six-month periods, while total expenses rose to Rs 1,485.36 crore from Rs 1,277.47 crore.

The September 2026 quarter also differed from the immediately preceding June 2026 quarter, when Jyothy Labs reported revenue from operations of Rs 773.40 crore and net profit of Rs 47.64 crore. Basic earnings per share were Rs 0.29 in the September 2026 quarter, compared with Rs 1.30 in June 2026 and Rs 2.39 in September 2025; all three quarterly figures were stated as not annualised.

Conclusion

Jyothy Labs has approved a defined tender offer with a maximum cash commitment of Rs 147 crore and Rs 150 for up to 68,37,210 shares at Rs 215 each. The proposal covers 1.86% of paid-up equity capital and is within the disclosed 10% board-route ceiling, while the promoter and promoter group have said they will not tender shares.

The next disclosed milestone is the November 11, 2026 record date. Until one working day before that date, the board or buyback committee may raise the Rs 215 price and reduce the maximum share quantity without changing the outlay; the subsequent public announcement and letter of offer are expected to provide the tender procedure and timetable.